Insights From Our Labs to Yours Labcorp Drug Development Blog NAVIGATION Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials. Connecting Expertise to Accelerate Lab Testing Innovations at Labcorp Central Laboratory Services Anti-Drug Antibody (ADA) Positive Controls Generation Against Oligonucleotide Therapeutics: Anti-Oligonucleotide Antibody Case Study Load More Posts LANGUAGES: 简体中文 Français Deutsch 日本語 Español English CATEGORY About Us (1) Analytical Services (3) Antibodies (1) Autoimmune/Inflammatory (12) Biologics (13) Biomarkers (11) Biosimilars (4) Cardiology (3) Cell/Gene Therapies (7) Chemical (16) Clinical Development (45) Clinical Testing (12) CNS (1) Commercialization (11) Consulting (2) Crop (13) Data/Informatics (16) Decentralized Clinical Trials (13) Device (14) Discovery (6) Drug (185) Formulation, Packaging, etc. (1) General Medicine (2) Health Economics & Market Access (5) Immunology (2) Industry (3) Infectious Disease (3) Inhalation (1) Lead Optimization (6) Manufacturing Support (1) Metabolic/Endocrine (11) Metabolism & PK (4) NASH (6) Nephrology (1) Oncology (37) Pathology (1) Patient Recruitment (8) Pediatrics (2) Phase I-IIa (20) Phase IIb-III (81) Pilot (4) Pivotal (12) Preclinical/Nonclinical (109) Pulmonary/Respiratory (5) Rare Disease (8) Regulatory Agencies (2) Regulatory Milestones (1) Renal/Hepatic (2) Reproductive Health (1) Risk Management (4) Routes (1) Safety (3) Safety Assessment (9) SEND (7) Small Molecules (7) Technology Services (2) Uncategorized (3) Vaccine (4) Vaccine (2) Xcellerate (7) ARCHIVES Archives Select Month November 2021 October 2021 September 2021 August 2021 July 2021 June 2021 May 2021 April 2021 March 2021 February 2021 January 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 October 2019 September 2019 August 2019 May 2019 April 2019 March 2019 February 2019 January 2019 December 2018 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 March 2018 February 2018 January 2018 November 2017 October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 November 2016 September 2016 August 2016 July 2016 June 2016 May 2016 April 2016 March 2016 February 2016 January 2016 November 2015 August 2015 June 2015 March 2015 TAGS biologics Biomarkers biosimilars cancer CDx central laboratory services Chemical China Clinical Development clinical trials CMC commercialization Companion Diagnostics COVID-19 CRO Crop Protection dart data management Decentralized Clinical Trials (DCT) Decentralized Trials Diabetes Diabetic Kidney Disease Drug Development Drug Safety FDA Immuno-Oncology informatics Market Access medical device NAFLD NASH Oncology Patient Centricity Patient Recruitment Pharmacovigilance precision medicine Rare Diseases REACH Real-World Evidence Regulatory Rheumatoid Arthritis send Vaccine Development vaccines Xcellerate Copyright © 2021 Labcorp All rights reserved.